On August 12, 2025, ParkerVision, Inc. announced its results for the three and six months ended June 30, 2025, reporting no licensing revenue for the period. The company posted a net loss of $1.634 million for the second quarter of 2025, a significant increase from $327,000 in the same period of 2024.
For the six months ended June 30, 2025, the net loss widened to $5.433 million, up from $1.020 million in the prior year period. Operating expenses surged, with selling, general, and administrative (SG&A) expenses increasing by $3.2 million (462.7%) for the second quarter, partly due to a $2.5 million one-time, non-cash charge related to executive share options.
The company reported negative cash flows from operations of approximately $3.0 million for the first half of 2025. As of June 30, 2025, ParkerVision held only approximately $2.0 million in cash and cash equivalents, alongside an accumulated deficit of approximately $453.6 million and a working capital deficit of $0.2 million.
Management explicitly stated that there is 'substantial doubt about our ability to continue to operate as a going concern for a period of one year.' This highlights the company's precarious financial health and its heavy reliance on future proceeds from patent enforcement actions to sustain operations and meet its obligations.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.